1. Home
  2. IMNN vs MHUA Comparison

IMNN vs MHUA Comparison

Compare IMNN & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • MHUA
  • Stock Information
  • Founded
  • IMNN 1982
  • MHUA 1990
  • Country
  • IMNN United States
  • MHUA China
  • Employees
  • IMNN N/A
  • MHUA N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • IMNN Health Care
  • MHUA Health Care
  • Exchange
  • IMNN Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • IMNN 12.9M
  • MHUA 13.3M
  • IPO Year
  • IMNN 1985
  • MHUA 2022
  • Fundamental
  • Price
  • IMNN $5.10
  • MHUA $0.40
  • Analyst Decision
  • IMNN Buy
  • MHUA
  • Analyst Count
  • IMNN 2
  • MHUA 0
  • Target Price
  • IMNN $182.61
  • MHUA N/A
  • AVG Volume (30 Days)
  • IMNN 160.1K
  • MHUA 196.8K
  • Earning Date
  • IMNN 11-06-2025
  • MHUA 09-19-2025
  • Dividend Yield
  • IMNN N/A
  • MHUA N/A
  • EPS Growth
  • IMNN N/A
  • MHUA N/A
  • EPS
  • IMNN N/A
  • MHUA 0.29
  • Revenue
  • IMNN N/A
  • MHUA $89,547,563.00
  • Revenue This Year
  • IMNN N/A
  • MHUA N/A
  • Revenue Next Year
  • IMNN N/A
  • MHUA N/A
  • P/E Ratio
  • IMNN N/A
  • MHUA $1.38
  • Revenue Growth
  • IMNN N/A
  • MHUA N/A
  • 52 Week Low
  • IMNN $4.70
  • MHUA $0.25
  • 52 Week High
  • IMNN $41.22
  • MHUA $1.17
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 41.04
  • MHUA 57.66
  • Support Level
  • IMNN $4.91
  • MHUA $0.37
  • Resistance Level
  • IMNN $5.39
  • MHUA $0.43
  • Average True Range (ATR)
  • IMNN 0.24
  • MHUA 0.03
  • MACD
  • IMNN 0.00
  • MHUA 0.00
  • Stochastic Oscillator
  • IMNN 26.51
  • MHUA 86.13

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: